跳至主要内容
临床试验/NCT02862327
NCT02862327已完成3 期

Intravenous Dexamethasone Versus Placebo for Ultrasound Guided Axillary Brachial Plexus Block With Ropivacaine: Randomised, Controlled, Clinical Trial

Centre Hospitalier Universitaire de Besancon1 个研究点 分布在 1 个国家目标入组 99 人开始时间: 2016年12月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
已完成
入组人数
99
试验地点
1
主要终点
Analgesia duration after axillary brachial plexus block

研究概览

简要总结

Prospective monocentric double-blind controlled randomised trial Aim is to assess prolonged postsurgical analgesia by intravenous dexamethasone versus intravenous placebo, after ultrasound guided axillary brachial plexus block

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • ASA 1,2 et 3
  • surgery under axillary brachial plexus block
  • aged >18 years
  • signed information consent

排除标准

  • impaired coagulation
  • contraindication to regional anesthesia or technical impossibility
  • opioids or pain killers abuse or addiction
  • steroids consumption in the past 6 months
  • dementia or under administrative supervision
  • delay of surgery to short to allow regional anesthesia
  • pregnancy and breastfeeding
  • allergy and contraindication to dexamethasone or ropivacaine
  • anticipated bad observation of treatment
  • patient enrolled in another trial

研究组 & 干预措施

intravenous dexamethasone

Active Comparator

intravenous injection of 8mg (2ml) of dexamethasone during regional anesthesia

干预措施: intravenous dexamethasone (Drug)

intravenous dexamethasone

Active Comparator

intravenous injection of 8mg (2ml) of dexamethasone during regional anesthesia

干预措施: perineural ropivacaine (Drug)

intravenous dexamethasone

Active Comparator

intravenous injection of 8mg (2ml) of dexamethasone during regional anesthesia

干预措施: ultrasound guidance (Other)

intravenous placebo

Placebo Comparator

intravenous injection of 2ml of NaCl 0.9% during regional anesthesia

干预措施: intravenous placebo (Drug)

intravenous placebo

Placebo Comparator

intravenous injection of 2ml of NaCl 0.9% during regional anesthesia

干预措施: perineural ropivacaine (Drug)

intravenous placebo

Placebo Comparator

intravenous injection of 2ml of NaCl 0.9% during regional anesthesia

干预措施: ultrasound guidance (Other)

结局指标

主要结局

Analgesia duration after axillary brachial plexus block

时间窗: time to first pain at surgical site, an average of 24 hours

次要结局

  • Motor block duration after axillary brachial plexus block Safety(up to block recovery, an average of 24 hours)
  • Sensory block duration after axillary brachial plexus block(up to block recovery, an average of 24 hours)
  • incidence of adverse event(6 month)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验